Relief Therapeutics Holding AG

RLFTD · OTC
Analyze with AI
12/31/2024
6/30/2024
12/31/2023
6/30/2023
Operating Activities
Net Income-$13-$5-$42-$56
Dep. & Amort.$1$1$2$2
Deferred Tax-$3$1-$6-$8
Stock-Based Comp.$0$0$0$1
Change in WC$3-$0-$0-$1
Other Non-Cash$12-$0$44$56
Operating Cash Flow$0-$3-$7-$10
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0-$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$4$0$9$0
Investing Cash Flow$4-$0$9-$0
Financing Activities
Debt Repay.-$0$0-$0-$0
Stock Issued$0$0$0$5
Stock Repurch.$0$0-$0-$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0-$1-$0$5
Financing Cash Flow-$0-$1-$0$4
Forex Effect$0$0$0$0
Net Chg. in Cash$0-$4$2-$6
Supplemental Information
Beg. Cash$11$15$13$19
End Cash$15$11$15$13
Free Cash Flow$0-$3-$7-$11
Relief Therapeutics Holding AG (RLFTD) Financial Statements & Key Stats | AlphaPilot